Masimo Corporation (MASI): Price and Financial Metrics


Masimo Corporation (MASI): $223.65

-9.43 (-4.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MASI POWR Grades


  • MASI scores best on the Quality dimension, with a Quality rank ahead of 88.6% of US stocks.
  • The strongest trend for MASI is in Stability, which has been heading up over the past 155 days.
  • MASI ranks lowest in Momentum; there it ranks in the 14th percentile.

MASI Stock Summary

  • With a one year PEG ratio of 5,317.71, Masimo Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.18% of US stocks.
  • Price to trailing twelve month operating cash flow for MASI is currently 60.97, higher than 92.93% of US stocks with positive operating cash flow.
  • The ratio of debt to operating expenses for Masimo Corp is higher than it is for about only 0.39% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Masimo Corp, a group of peers worth examining would be CRTO, ABMD, ICUI, QDEL, and GMED.
  • MASI's SEC filings can be seen here. And to visit Masimo Corp's official web site, go to www.masimo.com.

MASI Valuation Summary

  • In comparison to the median Healthcare stock, MASI's price/sales ratio is 234.21% higher, now standing at 12.7.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.

Below are key valuation metrics over time for MASI.

Stock Date P/S P/B P/E EV/EBIT
MASI 2021-08-31 12.7 10.7 66.8 55.7
MASI 2021-08-30 12.9 10.9 68.0 56.8
MASI 2021-08-27 13.0 11.0 68.2 57.0
MASI 2021-08-26 12.9 10.9 68.0 56.8
MASI 2021-08-25 13.1 11.1 69.1 57.7
MASI 2021-08-24 13.3 11.3 70.2 58.7

MASI Growth Metrics

    Its year over year cash and equivalents growth rate is now at -8.9%.
  • Its year over year net income to common stockholders growth rate is now at 8.46%.
  • The 5 year price growth rate now stands at 400.85%.
Over the past 15 months, MASI's revenue has gone up $159,530,000.

The table below shows MASI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 1,206.629 231.569 232.058
2021-06-30 1,177.327 190.161 223.692
2021-03-31 1,173.162 227.868 229.229
2020-12-31 1,143.744 210.963 240.302
2020-09-30 1,096.2 216.769 222.554
2020-06-30 1,047.099 226.921 222.234

MASI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASI has a Quality Grade of B, ranking ahead of 88.45% of graded US stocks.
  • MASI's asset turnover comes in at 0.714 -- ranking 51st of 186 Medical Equipment stocks.
  • BLFS, NVNO, and ZYXI are the stocks whose asset turnover ratios are most correlated with MASI.

The table below shows MASI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-02 0.714 0.647 0.384
2021-07-03 0.702 0.642 0.380
2021-04-03 0.705 0.643 0.387
2021-01-02 0.700 0.650 0.408
2020-09-26 0.705 0.660 0.413
2020-06-27 0.720 0.669 0.414

MASI Price Target

For more insight on analysts targets of MASI, see our MASI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $298.80 Average Broker Recommendation 1.56 (Moderate Buy)

MASI Stock Price Chart Interactive Chart >

Price chart for MASI

MASI Price/Volume Stats

Current price $223.65 52-week high $305.21
Prev. close $233.08 52-week low $205.10
Day low $223.42 Volume 309,487
Day high $229.49 Avg. volume 388,955
50-day MA $280.18 Dividend yield N/A
200-day MA $261.44 Market Cap 12.35B

Masimo Corporation (MASI) Company Bio


Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.


MASI Latest News Stream


Event/Time News Detail
Loading, please wait...

MASI Latest Social Stream


Loading social stream, please wait...

View Full MASI Social Stream

Latest MASI News From Around the Web

Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Retrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People

IRVINE, Calif., January 18, 2022--An abstract presented at STA found that Masimo SET® pulse oximetry had no clinically significant bias based on ethnicity for black or white subjects.

Yahoo | January 18, 2022

HighTower Trust Services, LTA Buys Amazon. ...

Investment company HighTower Trust Services, LTA (Current Portfolio) buys Amazon.com Inc, iShares Core S&P 500 ETF, Netflix Inc, American Tower Corp, Masimo Corp, sells Raytheon Technologies Corp, Upland Software Inc, Verizon Communications Inc, The Walt Disney Co, Schlumberger during the 3-months ended 2021Q4, according to the most recent filings of the investment company, HighTower Trust Services, LTA.

Yahoo | January 14, 2022

Masimo (MASI) Provides FY22 View, Preliminary FY21 Results Solid

Masimo's (MASI) solid full-year results likely to have been boosted by strong product sales.

Yahoo | January 13, 2022

Masimo (MASI) Receives a Hold from BTIG

BTIG analyst Marie Thibault maintained a Hold rating on Masimo (MASI – Research Report) today. The company's shares closed last Tuesday at $248.70. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 28.3% and a 38.3% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Masimo with a $323.33 average price target. See the top stocks recommended by analysts >> The company has a one-year high of $305.21 and a one-year low of $205.10.

Catie Powers on TipRanks | January 11, 2022

Masimo sees FY21 revenue growth of 8%

Masimo (MASI) expects that its product revenue for FY21 will range from $1.235 to $1.24B which marks growth of ~8% to 8.4% and constant currency growth of 7.3% to 7.7%,

Seeking Alpha | January 11, 2022

Read More 'MASI' Stories Here

MASI Price Returns

1-mo -20.15%
3-mo -20.35%
6-mo -17.37%
1-year N/A
3-year 85.42%
5-year 211.53%
YTD -23.61%
2021 9.09%
2020 69.80%
2019 47.21%
2018 26.62%
2017 25.82%

Continue Researching MASI

Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:

Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0157 seconds.